General Discussion, page-12

You can all discuss charting the stock until the cows cows home, but unless the business actually makes some sales and generates some cash, it will be out of cash shortly.

Monthly spend is still over $750k/month, cash reserves as at Dec 31, 2023 were $1.5M globally ( 2 months spend) with the only known cash coming in being R&D grant if it follows the same timeframe as last year.

The half year accounts are due at the end of this month and will be interesting to see what rabbits are pulled out of the hat to give the auditors any additional level of comfort over their previous reports doubting the going concern ability of the business. Surely they can't just keep saying the same thing with nothing more substantial being announced. A more damning statement by the auditors may be coming, even in the half year review.